Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Iopamidol Injection

Approval Number

国药准字H20237170

Company广州康臣药业有限公司

Registration Date

May 14, 2024

Previous Approval Numbers

国药准字H20193195

Drug Information

Generic Name

碘帕醇注射液

Dosage Form

注射剂

Strength

75ml:27.75g(I)

Drug Type

化学药品

Registration Date

May 14, 2024

Company Information

Applicant Company

Company Name广州康臣药业有限公司

Company Address

广州萝岗区经济技术开发区东区东鹏大道71号

Manufacturing Company

Company Name广州康臣药业有限公司

Company Address

广州经济技术开发区东区东鹏大道71号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

碘帕醇注射液 - NMPA 批准文号 | MedPath